As part of its strategy to administer the vaccine as quickly as possible, the Trump administration has agreed to invest more than half a billion in tax dollars in ApiJect Systems America, a young company whose injector is not approved by federal health authorities and that hasn't yet set up a factory to manufacture the devices.
As part of its strategy to administer the vaccine as quickly as possible, the Trump administration has agreed to invest more than half a billion in tax dollars in ApiJect Systems America, a young company whose injector is not approved by federal health authorities and that hasn't yet set up a factory to manufacture the devices.
The government promised ApiJect $138 million to produce 100 million of its devices by the end of the year, which will require the company to retrofit new manufacturing lines in existing factories. And it's offered another $456 million as part of a public-private partnership contract to bring online several new factories to make another 500 million devices to "contain the pandemic spread to minimize the loss of life and impact to the United States economy," said the document.
According to Walker, the CEO, ApiJect wasn't interested in a federal contract — they were aiming to change the developing world with quick, inexpensive injection devices that could save millions of lives. Walker continued to resist, he said, but Giroir — who is also a doctor specializing in pediatric critical care — "wasn't big on taking no for an answer," Walker said.
When the pandemic emerged weeks later, officials sounded the alarm about a potential shortage of needles and syringes to deliver a vaccine if and when one became available. He recommended the task force "direct HHS BARDA to initiate a program to identify all alternate vaccine delivery methods and ramp up production." BARDA is the Biomedical Advanced Research and Development Authority within HHS.
An estimated 700 million injections may be needed to inoculate the nation -- at least two shots for every person, according to the military document. And earlier this month Retractable entered into a second contract with the government, this one for $53 million meant to boost domestic manufacturing.But Retractable, which was worried enough about its financial future that earlier this year it received a $1.36 million loan from the Paycheck Protection Program, has been doing about 80% of its manufacturing in China.
The device includes a little computer chip — like the ones in credit cards — that can transmit information about the drug, dose, location and time of administration.
All the earmarks of an orange TURD-IN-CHIEF'S administration paying someone back for their support. Such overt criminals leading our country. TAKE AMERICA BACK AGAIN!!!
There is no way this company can have that many injectors ready by the end of the year. Check the investors someone is apart of Trumpland.
Wondering how much insider trading is going on from within the families of WhiteHouse administration?!?
They obviously own stock 🤷🏽♂️ this whole clown show has shown they care about nobody but themselves
CLOWNS at the finest levels
Wonder what Trump associate owns that company.
Trump and Trumpers are hallucinating.
I have already warned you all. Trump will massively screw up the vaccine roll-out once the vaccine is developed
Alternative headline. US steals future income of unborn Americans to fund a company that will not produce a vaccine.
bullish
This news brings some hope.
TRUMP AND KUSHNER ARE MURDERING AMERICAN CITIZENS TO BENEFIT THEIR FOREIGN MASTERS AND FOR PROFIT (fixed it for you)
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »